Inflammatory bowel disease in children: Psychological and psychiatric issues

Current Psychiatry Reports

Volumn 12, Issue 3, 2010, Pages 222-228

  Deshmukh, Parikshit ^a   Kulkarni, Gaurav ^b   Lackamp, Jeanne ^a  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b GOVERNMENT MEDICAL COLLEGE   (India)

Author keywords

Adolescents; Children; IBD; Inflammatory bowel disease; Psychiatric; Psychotherapy; Treatment

Indexed keywords

AMFEBUTAMONE; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; CITALOPRAM; CORTICOSTEROID; FLUOXETINE; FLUVOXAMINE; METHOTREXATE; MIRTAZAPINE; NEUROLEPTIC AGENT; PAROXETINE; PHENELZINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TACROLIMUS;

ACADEMIC FAILURE; AGGRESSION; ANOREXIA NERVOSA; ANXIETY; ANXIETY DISORDER; ARTHRITIS; BRAIN DISEASE; CHILD; CLINICAL TRIAL; COGNITIVE BEHAVIORAL STRESS MANAGEMENT; COGNITIVE DEFECT; COMORBIDITY; CROHN DISEASE; DELIRIUM; DEPRESSION; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISTRESS SYNDROME; DRUG DEPENDENCE; DRUG EFFICACY; DRUG SAFETY; ENTERITIS; EUPHORIA; FAMILY HISTORY; HEALTH CARE UTILIZATION; HUMAN; HYPOMANIA; INSOMNIA; IRRITABLE COLON; MAJOR DEPRESSION; MEDICAL LITERATURE; MENTAL DISEASE; MOOD CHANGE; MOOD DISORDER; NARCOLEPSY; NEUROPSYCHOLOGICAL TEST; PREVALENCE; PSYCHODYNAMICS; PSYCHOEDUCATION; PSYCHOPHARMACOLOGY; PSYCHOPHARMACOTHERAPY; PSYCHOSIS; PSYCHOTHERAPY; QUALITY OF LIFE; RELAXATION TRAINING; REVIEW; SIDE EFFECT; SLEEP DISORDER; SOCIAL PSYCHOLOGY; SUICIDE; ULCERATIVE COLITIS; WEIGHT REDUCTION; ADOLESCENT; ARTICLE; FEMALE; MALE; PSYCHOLOGICAL ASPECT; UNITED STATES;

ADOLESCENT; CHILD; FEMALE; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; MENTAL DISORDERS; PREVALENCE; PSYCHOTHERAPY; UNITED STATES;

EID: 77955300649     PISSN: 15233812     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11920-010-0111-0     Document Type: Review

References (57)

1. Verhoef M, Sutherland LR: Outpatient health care utilization of patients with inflammatory bowel disease. Dig Dis Sci 1990, 35:1276-1280.
2. Kappelman MD, Rifas-Shiman SL, Kleinman K, et al.: The prevalence and geographic distribution of Crohn's disease and ulcerative colitis in the United States. Clin Gastroenterol Hepatol 2007, 5:1424-1429. This study neatly outlines the prevalence, severity, and geographical distribution of IBD in US children.
3. Armitage E, Drummond HE, Wilson DC, Ghosh S: Increasing incidence of both juvenile-onset Crohn's disease and ulcerative colitis in Scotland. Eur J Gastroenterol Hepatol 2001, 13:1439-1447.
4. Phavichitr N, Cameron DJ, Catto-Smith AG: Increasing incidence of Crohn's disease in Victorian children. J Gastroenterol Hepatol 2003, 18:329-332.
5. Szigethy EM, Levy-Warren A, Whitton S, et al.: Depressive symptoms and inflammatory bowel disease in children and adolescents: A cross-sectional study. J Pediatr Gastroenterol Nutr 2004, 39:395-403.
6. Adler J, Raju S, Beveridge AS, et al.: College adjustment in University of Michigan students with Crohn's and colitis. Inflamm Bowel Dis 2008, 14:1281-1286. In this study, the effect of IBD on adjustment of college students is reviewed, including the need for early intervention to improve future functioning.
7. Yang YX, Lichtenstein GR: Corticosteroids in Crohn's disease. Am J Gastroenterol 2002, 97:803-823.
8. Hall AS, Thorley G, Houtman PN: The effects of corticosteroids on behavior in children with nephrotic syndrome. Pediatr Nephrol 2003, 18:1220-1223.
9. Warrington TP, Bostwick JM: Psychiatric adverse effects of corticosteroids. Mayo Clin Proc 2006, 81:1361-1367.
10. Ng SC, Arebi N, KammMA:Medium-term results of oral tacrolimus treatment in refractory inflammatory bowel disease. Inflamm Bowel Dis 2007, 13:129-134.
11. Lowry PW, Weaver AL, Tremaine WJ, Sandborn WJ: Combination therapy with oral tacrolimus (FK506) and azathioprine or 6- mercaptopurine for treatment-refractory Crohn's disease perianal fistulae. Inflamm Bowel Dis 1999, 5:239-245.
12. Kemper MJ, Spartà G, Laube GF, et al.: Neuropsychologic sideeffects of tacrolimus in pediatric renal transplantation. Clin Transplant 2003, 17:130-134.
13. Hausmann J, Zabel K, Herrmann E, Schröder O: Methotrexate for maintenance of remission in chronic active Crohn's disease: Longterm single-center experience and meta-analysis of observational studies. Inflamm Bowel Dis 2009 Nov 18 (Epub ahead of print).
14. Atzeni F, Ardizzone S, Bertani L, et al.: Combined therapeutic approach: Inflammatory bowel diseases and peripheral or axial arthritis. World J Gastroenterol 2009, 15:2469-2471.
15. Sioka C, Kyritsis AP: Central and peripheral nervous system toxicity of common chemotherapeutic agents. Cancer Chemother Pharmacol 2009, 63:761-767.
16. Arfaoui D, Elloumi H, Debbebi W, et al.: Psychological disorder associated to inflammatory bowel disease [in French]. Tunis Med 2007, 85:189-191.
17. Mackner LM, Crandall WV: Brief report: Psychosocial adjustment in adolescents with inflammatory bowel disease. J Pediatr Psychol 2006, 31:281-285.
18. Burke P, Meyer V, Kocoshis S, et al.: Depression and anxiety in pediatric inflammatory bowel disease and cystic fibrosis. J Am Acad Child Adolesc Psychiatry 1989, 28:948-951.
19. Burke PM, Neigut D, Kocoshis S, et al.: Correlates of depression in new onset pediatric inflammatory bowel disease. Child Psychiatry Hum Dev 1994, 24:275-283.
20. Engstrom I: Mental health and psychological functioning in children and adolescents with inflammatory bowel disease: A comparison with children having other chronic illnesses and with healthy children. J Child Psychol 1992, 33:563-582.
21. Szajnberg N, Krall V, Davis P, et al.: Psychopathology and relationship measures in children with inflammatory bowel disease and their parents. Child Psychiatry Hum Dev 1993, 23:215-232.
22. Burke P, Meyer V, Kocoshis S, et al.: Obsessive-compulsive symptoms in childhood inflammatory bowel disease and cystic fibrosis. J Am Acad Child Adolesc Psychiatry 1989, 28:525-527.
23. Burke P, Kocoshis SA, Chandra R, et al.: Determinants of depression in recent onset pediatric inflammatory bowel disease. J Am Acad Child Adolesc Psychiatry 1990, 29:608-610.
24. Burke PM, Kocoshis S, Neigut D, et al.: Maternal psychiatric disorders in pediatric inflammatory bowel disease and cystic fibrosis. Child Psychiatry Hum Dev 1994, 25:45-52.
25. Ferry GD: Quality of life in inflammatory bowel disease: Background and definitions. J Pediatr Gastroenterol Nutr 1999, 28:S15-S18.
26. Rabbett H, Elbadri A, Thwaites R, et al.: Quality of life in children with Crohn's disease. J Pediatr Gastroenterol Nutr 1996, 23:528-533.
27. De Boer M, Grootenhuis M, Derkx B, Last B: Health-related quality of life and psychosocial functioning of adolescents with inflammatory bowel disease. Inflamm Bowel Dis 2005, 11:400-406.
28. Engstrom I: Parental distress and social interaction in families with children with inflammatory bowel disease. J Am Acad Child Adolesc Psychiatry 1991, 30:904-912.
29. Nicholas DB, Swan SR, Gerstle TJ, et al.: Struggles, strengths, and strategies: An ethnographic study exploring the experiences of adolescents living with an ostomy. Health Qual Life Outcomes 2008, 6:114.
30. Addolorato G, Capristo E, Stefanini GF, Gasbarrini G: Inflammatory bowel disease: A study of the association between anxiety and depression, physical morbidity, and nutritional status. Scand J Gastroenterol 1997, 32:1013-1021.
31. Tarter RE, Switala J, Carra J, et al.: Inflammatory bowel disease: Psychiatric status of patients before and after disease onset. Int J Psychiatry Med 1987, 17:173-181.
32. Kaplan MA, Korelitz BJ: Narcotic dependence in inflammatory bowel disease. J Clin Gastroenterol 1988, 10:275-278.
33. Fuller-Thomson E, Sulman J: Depression and inflammatory bowel disease: Findings from two nationally representative Canadian surveys. Inflamm Bowel Dis 2006, 12:697-707.
34. Cuntz U, Welt J, Ruppert E, Zillessen E: Determination of subjective burden from chronic inflammatory bowel disease and its psychosocial consequences. Results from a study of 200 patients. Psychother Psychosom Med Psychol 1999, 49:494-500.
35. Andrews H, Barczak P, Allan RN: Psychiatric illness in patients with inflammatory bowel disease. Gut 1987, 28:1600-1604.
36. Nigro G, Angelini G, Grosso SB, et al.: Psychiatric predictors of noncompliance in inflammatory bowel disease: Psychiatry and compliance. J Clin Gastroenterol 2001, 32:66-68.
37. Mittermaier C, Dejaco C,Waldhoer T, et al.: Impact of depressive mood on relapse in patients with inflammatory bowel disease: A prospective 18-month follow-up study. Psychosom Med 2004, 66:79-84.
38. Kurina LM, Goldacre MJ, Yeates D, Gill LE: Depression and anxiety in people with inflammatory bowel disease. J Epidemiol Community Health 2001, 55:716-720.
39. Walker EA, Gelfand MD, Gelfand AN, et al.: The relationship of current psychiatric disorder to functional disability and distress in patients with inflammatory bowel disease. Gen Hosp Psychiatry 1996, 18:220-229.
40. Szigethy E, Kenney E, Carpenter J, et al.: Cognitive-behavioral therapy for adolescents with inflammatory bowel disease and subsyndromal depression. J Am Acad Child Adolesc Psychiatry 2007, 46:1290-1298. The authors demonstrated the efficacy of 12 to 14 weeks of cognitive-behavioral therapy in treating adolescent IBD patients with depressive symptoms.
41. Deter HC, Keller W, von Wietersheim J, et al.: Psychological treatment may reduce the need for healthcare in patients with Crohn's disease. Inflamm Bowel Dis 2007, 13:745-752. Deter and colleagues revealed the obvious benefit of implementing psychotherapy (in addition to glucocorticoid therapy) in CD patients, as it reduced health care use by decreasing in-hospital days and sick leaves (P<0.03)
42. Deter HC, von Wietersheim J, Jantschek G, et al.: High-utilizing Crohn's disease patients under psychosomatic therapy. Biopsychosoc Med 2008, 13:18. In this prospective, multicenter study, a significant drop in health care use was observed after psychosomatic therapy in high health care-utilizing patients with CD.
43. Schwarz SP, Blanchard EB: Evaluation of a psychological treatment for inflammatory bowel disease. Behav Res Ther 1991, 29:167-177.
44. Elsenbruch S, Langhorst J, Popkirowa K, et al.: Effects of mind- body therapy on quality of life and neuroendocrine and cellular immune functions in patients with ulcerative colitis. Psychother Psychosom 2005, 74:277-287.
45. Maunder RG, Esplen MJ: Supportive-expressive group psychotherapy for persons with inflammatory bowel disease. Can J Psychiatry 2001, 46:622-626.
46. GrootenhuisMA,Maurice-Stam H, Derkx BH, Last BF: Evaluation of a psychoeducational intervention for adolescents with inflammatory bowel disease. Eur J Gastroenterol Hepatol 2009, 21:430-435. In this study, nonpharmacologic methods, including psychoeducation, were observed to be important for improving IBD patients' lives.
47. Shepanski MA, Hurd LB, Culton K, et al.: Health-related quality of life improves in children and adolescents with inflammatory bowel disease after attending a camp sponsored by the Crohn's and Colitis Foundation ofAmerica. Inflamm BowelDis 2005, 11:164-170.
48. Jackson JL, O'Malley PG, Tomkins G, et al.: Treatment of functional gastrointestinal disorders with antidepressant medications: A metaanalysis. Am J Med 2000, 108:65-72.
49. Mikocka-Walus AA, Turnbull DA, Moulding NT, et al.: It doesn't do any harm, but patients feel better: A qualitative exploratory study on gastroenterologists' perspectives on the role of antidepressants in inflammatory bowel disease. BMC Gastroenterol 2007, 24:38.
50. Kast RE, Altschuler EL: Remission of Crohn's disease on bupropion. Gastroenterology 2001, 121:1260-1261.
51. Tuglu C, Kara SH, Caliyurt O, et al.: Increased serum tumor necrosis factor-alpha levels and treatment response in major depressive disorder. Psychopharmacology (Berl) 2003, 170:429-433.
52. Mikocka-Walus AA, Turnbull DA, Moulding NT, et al.: Antidepressants and inflammatory bowel disease: A systematic review. Clin Pract Epidemol Ment Health 2006, 2:24.
53. Hammad T, Laughren T, Racoosin JA: Suicidality in pediatric patients treated with antidepressant drugs. Arch Gen Psychiatry 2006, 63:332-339.
54. Chungh DS, Kim BN, Cho SC: Neuroleptic malignant syndrome due to three atypical antipsychotics in a child. J Psychopharmacol 2005, 19:422-425.
55. Birchley G: Opioid and benzodiazepine withdrawal syndromes in the paediatric intensive care unit: A review of recent literature. Nurs Crit Care 2009, 14:26-37.
56. Murphy TK, Segarra A, Storch EA, Goodman WK: SSRI adverse events: How to monitor and manage. Int Rev Psychiatry 2008, 20:203-208.
57. Findling RL: Atypical antipsychotic treatment of disruptive behavior disorders in children and adolescents. J Clin Psychiatry 2008, 69(Suppl 4):9-14.